Obagi Medical Products - Comparative Multiple Analysis

Obagi Medical Products (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Obagi Medical Products

WikiWealth compares Obagi Medical Products's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Obagi Medical Products's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Obagi Medical Products.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Obagi Medical Products's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Obagi Medical Products's Analysis

How does this work? The Comparative Investment Analysis determines the value of Obagi Medical Products by comparing Obagi Medical Products financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Obagi Medical Products.

See the Obagi Medical Products cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Obagi Medical Products.

Also, see the Obagi Medical Products's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Obagi Medical Products's valuation conclusion for a quick summary.